Surprisingly, analyzing a publicly available database (https://depmap.org/portal/interactive/), we found that KRAS mutant lung adenocarcinomas (LUAD) were significantly more sensitive to FTis compared to KRAS wild-type cells [23]. The gene discussed is KRAS; the disease is lung adenocarcinoma.